News Novartis AG

Equities

NOVN

CH0012005267

Market Closed - Swiss Exchange Other stock markets 11:31:55 2024-05-08 am EDT			5-day change	1st Jan Change
90.54 ^CHF	+0.85%		+1.88%	+6.68%

May. 06	NOVARTIS AG : UBS maintains a Buy rating	ZD
May. 02	Health Care Flat Amid Mixed Earnings -- Health Care Roundup	DJ

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NOVARTIS AG : UBS maintains a Buy rating	May. 06	ZD
Health Care Flat Amid Mixed Earnings -- Health Care Roundup	May. 02	DJ
Sector Update: Health Care Stocks Softer Late Afternoon	May. 02	MT
Sector Update: Health Care Stocks Retreat Thursday Afternoon	May. 02	MT
Top Midday Stories: Novo Nordisk, Linde Shares Fall Post-Earnings; Peloton Shares Plummet After Announcing Job Cuts, CEO Change; Exxon-Pioneer Deal Gets FTC Approval With One Caveat	May. 02	MT
News Highlights : Top Company News of the Day - Thursday at 11 AM ET	May. 02	DJ
Novartis AG to Acquire Mariana Oncology in Deal Valued Up to $1.75 Billion.	May. 02	MT
News Highlights : Top Company News of the Day - Thursday at 9 AM ET	May. 02	DJ
Novartis : enters agreement to acquire Mariana Oncology, strengthening radioligand therapy pipeline	May. 02	PU
Novartis: acquisition of US-based Mariana Oncology	May. 02	CF
Switzerland's Novartis to Buy US-based Mariana Oncology for $1 Billion Upfront	May. 02	MT
Novartis to Buy Mariana Oncology, Pay $1 Billion Upfront	May. 02	MT
Novartis AG to Acquire Mariana Oncology	May. 02	MT
Novartis AG to Acquire Mariana Oncology	May. 02	MT
Novartis to Buy Mariana Oncology for Up to $1.75 Billion in Boost to Radioligand Therapy Business	May. 02	DJ
Novartis to buy radiology specialist Mariana Oncology for $1 billion	May. 02	RE
Chimeric Therapeutics Appoints COO; Shares Rise 4%	May. 01	MT
Novartis AG entered into an agreement to acquire Mariana Oncology, Inc. from Atlas Venture L.P., Access Biotechnology, RA Capital Management, L.P., Deep Track Capital, LP, Forbion Capital Partners B.V. and others for $1.8 billion.	May. 01	CI
Avacta picks Christina Coughlin to replace long-serving CEO	May. 01	AN
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications	Apr. 30	MT